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Background: Circular ablation catheters (PVAC) have been shown to be effective in the
treatment of patients with paroxysmal atrial ﬁbrillation (PAF). The electrophysiological
characteristics of the pulmonary veins (PVs) during repeat procedures remain unknown.
Objective: To assess the efﬁcacy of PV isolation (PVI) using PVAC and to determine the
typical sites of electrical reconnection (ER) of PVs.
Methods: 79 patients with PAF underwent PVI using PVAC. Those who remained sympto-
matic underwent repeat procedure using a high-density 3D electroanatomical mapping to
determine the sites of ERs.
Results: In total, AF recurrence was documented in 33 patients (41.7%) during the mean
follow-up of 14277378 days. Twenty-two patients had a further ablation. ER of at least one
PV was found in all patients. Left upper, left lower, left common, right upper and right
lower PV showed ER in 15, 13, 3, 13 and 12 patients, respectively. There was no difference in
the number of ERs between individual PVs. In the left upper and left lower PV, 91.7% and
87.5% of gaps, respectively, were localized on the lateral ridge or carina. Sites of ER in the
right upper PV were clustered either in the posterior superior (75%) or in the anterior
inferior (25%) quadrants of the vein. Reconnection sites in the right lower PV were
scattered equally around its whole circumference.
Conclusion: Typical sites of PV ER are carina and the lateral ridge of the left PVs and
superior-posterior aspect of the right upper PV, whereas right lower PV seems to have no
typical “reconnection proﬁle”.
& 2013 The Czech Society of Cardiology. Published by Elsevier Urban & Partner Sp.z o.o. All
rights reserved.
.Introduction
Atrial ﬁbrillation (AF) ablation remains a relatively time-
consuming procedure in the electrophysiological laboratorych Society of Cardiology.
Cardiology, Ceske Budejo
20 387874325.
. Bulava).[1]. The number of patients suffering from this arrhythmia
continues to increase and with it the percentage of AF ablation
cases increases from year to year in high-volume centers.
Introduction of modern 3D mapping systems together withPublished by Elsevier Urban & Partner Sp.z o.o. All rights reserved.
vice Hospital, Bozeny Nemcove 585/54, 370 01 Ceske Budejovice,
.
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signiﬁcantly lower ﬂuoroscopic times [2,3], yet the total pro-
cedural duration time has not been affected much for the last
5–8 years and depends on the operator0s skills rather than on
the technology used. In a randomized trial we have recently
showed that pulmonary vein isolation (PVI) using phased array
radiofrequency (RF) energy and circular ablation catheters is,
in the short-term follow-up of 6 months, as effective as “point-
by-point” ablation using CARTO mapping system and both
procedural and ﬂuoroscopic times can be reduced to almost
half [4]. Such data were supported by other observational
studies [5].
In contrast to sequential point-by-point ablation, the use
of circular ablation catheter consists of simultaneous RF
energy deployment at the PV-left atrial (LA) junction. Conse-
quently, PVI can be achieved by only three or four 1-min
“burns” with progressive rotation of the catheter. Although
such a concept is technically very attractive, it also implies
that energy delivery cannot be properly varied across the
ablation lesion. Energy variation may be desirable at regions
of enhanced muscular thickness, such as the lateral ridge
between the left-sided veins and left atrial appendage (LAA).
We hypothesized that areas of electrical reconnection (ER)
after PVI using a decapolar circular ablation catheter (PVAC™,
Medtronic, USA) combined with a multichannel, duty-cycled
RF generator (GENius, Medtronic, USA) are not randomly
distributed around the PV ostia, but are preferentially located
at sites with increased muscular thickness. Knowledge of
such areas may be the basis for improved technique of PVI
using PVAC and long-term success. Further goals of the study
were to investigate the clinical efﬁcacy of PVI using PVAC
after a single procedure and after the ﬁrst re-ablation using a
3D electroanatomical mapping system.Methods
Patients
Seventy-nine consecutive patients between the years 2009
and 2010 with paroxysmal AF were prospectively recruited in
the study and followed for at least 2 years. AF was considered
paroxysmal if patients had a history of recurrent, self-
terminating episodes of arrhythmia spontaneously convert-
ing to normal SR, or either electrically of pharmacologically
cardioverted within 48 h if the symptoms were severe.
Patients without structural heart disease were not required
to try antiarrhythmic drugs. All patients were treated with
the PVAC, a ring-shaped multielectrode ablation catheter
using alternating uni- and bipolar-phased RF energy. None
of the patients had a prior RF ablation. Patients with sig-
niﬁcant structural abnormalities (left atrial (LA) dimension
Z50 mm, left ventricular ejection fraction (LVEF) r50%,
valvular insufﬁciency and/or stenosis Zgrade 3, hypertrophic
cardiomyopathy with septal thickness Z20 mm) were
excluded from the study. Other secondary causes of atrial
ﬁbrillation were also excluded. Transoesophageal echocardio-
graphy was performed within 24 h of the procedure to exclude
LA thrombus.CT imaging
Anatomy of the LA and PV is known to be highly individual
and variable. A 64-slice CT scan (Aquilion™ 64 TSX-101 A,
Toshiba) was performed on the day prior to the ablation
procedure, with subsequent 3D reconstruction of the anat-
omy using the CARTO MERGE™ or CARTO3™ software
(Biosense Webster Inc., Diamond Bar, CA, USA) to ensure that
all PVs were targeted for ablation in all but 2 patients. In these
2 patients we performed perioperative angiography of the LA.
Patients were not excluded from the study for anatomical
reasons after evaluating the CT anatomy of the LA.
Primary ablation procedure
A detailed description of PVAC ablation procedure can be
found elsewhere [4]. In brief, after successful transseptal
puncture the PVAC catheter was introduced into the LA via
a 9F steerable transseptal sheath (Channel, BARD Electro-
physiology, Lowell, MA, USA) and ablation in the antrum of
all PVs was accomplished under direct visualization using
intracardiac echocardiography (ICE). The standard ablation
setting was 4:1 bipolar to unipolar RF energy application
during 60 s, with a power limit of 8 W and target temperature
of 60 1C. Overlapping applications were performed until the
local antral voltage was abated. PVI with entrance block was
veriﬁed by mapping inside each vein using the PVAC and
ﬁnally using a conventional circular mapping catheter (Lasso,
Biosense Webster, Diamond Bar, CA, USA) at the end of the
procedure. If any ER was noted, the PVAC catheter was
reintroduced and ablation continued until the ﬁnal proof of
PVI. No pharmacological provocation (i.e. adenosine, isopro-
terenol) was used to facilitate acute electrical recovery of
the PVs.
Incremental atrial pacing was performed starting with a
cycle length (CL) of 400 ms and decreasing CL by 10 ms down
to 200 ms to test the inducibility of any atrial tachycardias
(AT). Cavotricuspid isthmus (CTI) ablation using 8 mm tip
conventional ablation catheter (Dual Sensor 8 mm, F curve,
Biosense Webster, Diamond Bar, CA, USA) was performed in
cases when sustained typical atrial ﬂutter (AFL) was induced.
Other ATs, if inducible, were not targeted by ablation. CTI
ablation was also performed in patients in whom typical
AFL was previously documented as a coinciding clinical
arrhythmia.
All procedures were carried out under conscious sedation
using a combination of fentanyl and diazepam. Heparin was
given after accessing the LA at a loading dose of 100 IU/kg and
continuous infusion to maintain a target ACT above 300 s.
Oral anticoagulation was restarted in all patients directly
after the procedure, using low-molecular weight heparin for
bridging until the INR was Z2.0.
Follow-up
A three-month blanking period was used and any recurrence
of AF during this period was not considered failure of
treatment. After the 3rd month following the index proce-
dure, the ﬁrst 7-day Holter was performed, and if no arr-
hythmia recurrence was detected, discontinuation of all
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were performed every three months after the procedure until
the 24th month, or redo procedure.
One-year success was deﬁned as freedom from AF/AFL/AT
lasting430 s off antiarrhythmic drug therapy from the end of
the three months blanking period to 12 months following the
ablation procedure[6]. Clinical success rate deﬁned as no
AF/AFL/AT recurrence during the whole follow-up period
after the ﬁrst and second procedures was also calculated.
Patients remained on oral anticoagulation therapy with
vitamin K antagonists with the target INR 2.5–3.0 throughout
the whole study if the CHA2DS2VASc was Z2. In patients
with lower CHA2DS2VASc score the anticoagulation therapy
was discontinued after 6 months following the index proce-
dure if no arrhythmia was detected both at the 3rd and 6th
month of follow-up.Fig. 1 – Schematic drawing of endoscopic view from inside
the left atrium. The antrum of each vein was segmented into
12 parts matching the numbers of a clock face. LSPV – left
superior pulmonary vein, LIPV – left inferior pulmonary
vein, RSPV – right superior pulmonary vein, RIPV – right
inferior pulmonary vein, LAA – left atrial appendage,
R – right side, L – left side, S – superior, I – inferior.Repeat ablation procedures
Repeat ablations were performed in all patients who were
symptomatic with documented episodes of AF or AT: 1.
despite reintroduction of the previous or alternative antiar-
rhythmic therapy, or 2. were not willing to use antiarrhyth-
mic drugs and/or oral anticoagulation therapy and preferred
to undergo a second ablation.
All redo procedures were carried out using the CARTO
3D mapping system (CARTO MERGE or later CARTO3).
After double transseptal puncture, two steerable transseptal
sheaths (8F, Channel, BARD Electrophysiology, Lowell, MA,
USA) were introduced into the LA and virtual reconstruction
of the anatomy was conducted acquiring at least 250 points
with the aim of detailed mapping of the PV antra. A circular
mapping catheter was used in all veins to conﬁrm isolation or
ER. RF energy was applied using a 3.5 mm irrigated-tip
Navistars catheter (Biosense Webster Inc., Diamond Bar,
CA, USA) with a temperature limitation of 44 1C and an RF
energy up to 35 W. The antrum of each vein was segmented
into 12 parts matching the numbers of a clock face as if
observed from inside the LA (i.e. endoscopic view, Fig. 1).
Detailed mapping of the PV antra was performed to ﬁnd the
earliest PV potential inside the presumed ablation line. Such
regions were targeted for ablation ﬁrst. Presence of a single
spot of ER (from now on referred to as a “gap”) corresponded
to the complete abolition of the PV potentials after a single RF
application at the spot with the earliest activation recorded in
the ablation catheter. Similarly, multiple gaps were deemed
to be present if the conduction time to the PV either
prolonged, or the PV potentials suddenly showed a different
activation pattern following RF application assuming that the
electrical activity in the ablation catheter was recorded earlier
than any of the PV potentials. Pacing maneuvers from several
LA sites (usually LAA, roof area and sites around the mitral
annulus) were also used to verify single activation patterns of
PV potentials corresponding to single gap or multiple activa-
tion patterns suggesting more than one gap. For each vein,
the number and location of gaps were recorded. After PVI
was achieved, pacing to each bipole of the Lasso catheter at
10 V/1 ms was delivered to prove “exit” block.Statistical analysis
Statistical analysis was performed using MedCalc software.
Continuous variables are expressed as mean7standard
deviation. Ranges are listed in the parenthesis when appro-
priate. Categorical variables are presented as percentages.
Comparisons between the two groups were made with a
Fisher0s exact test for categorical variables and an unpaired
t-test for continuous variables. In cases of non-normal data
distribution (Shapiro–Wilk test), a non-parametric Kruskal–
Wallis test was used, and for paired analysis a Mann–
Whitney U-test complemented with Bonferroni correction
was applied to limit a type I error at the level o0.05. A
p value o0.05 was considered statistically signiﬁcant.Results
Primary ablation procedure
Baseline clinical characteristics of 79 patients who underwent
primary PVI using PVAC are shown in Table 1. The mean
procedural and ﬂuoroscopy times were 105730 min (50–
192 min, median 96 min) and 15.175.3 min (7–34 min, med-
ian 14 min), respectively. No major complications occurred.
One large groin hematoma occurred, and one pseudoaneur-
ysm of the femoral artery was subsequently treated by
manual compression using an ultrasound probe without
need for any surgical intervention.
During the initial procedure, 307 of out 311 PVs were
considered isolated (98.7%). There were 9 patients (11.4%)
with left common PV trunk and 4 patients (5.1%) with
right accessory PV present in this study group. Isolation
was not accomplished despite repeated and prolonged RF
Table 1 – Baseline clinical characteristics of the patients
undergoing ﬁrst PVI procedure using PVAC.
N 79
Men 53 (67.1%)
Women 26 (32.9%)
Age (years) 59710 (31–81)
Concomitant diseases
Hypertension 27 (34.2%)
Diabetes 8 (10.1%)
Coronary artery disease 4 (5.1%)
Antiarrhythmic therapy
Propafenone 38 (48.1%)
Sotalol 22 (27.8%)
Amiodarone 15 (19%)
Left atrial diameter (mm) 41.175.2 (28–49)
Left ventricular ejection fraction (%) 6975 (60–80)
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Fig. 2 – Distribution of a number of electrical reconnections
found in each pulmonary vein during a repeat procedure.
Majority of pulmonary veins presented with only a single
site of reconduction. LSPV – left superior pulmonary vein,
LIPV – left inferior pulmonary vein, RSPV – right superior
pulmonary vein, RIPV – right inferior pulmonary vein.
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left superior PV in another patient). In one patient, AV nodal
re-entrant tachycardia was induced during incremental atrial
pacing and ablation of the slow pathway was subsequently
performed. The CTI was ablated in three patients because of
inducible typical atrial ﬂutter.
At 12 months, arrhythmia-free survival off antiarrhythmic
drugs reached 67.1%. In all patients with recurrent arrhyth-
mias the only documented tachycardia was AF. In total, AF
recurrences off-drugs were documented in 33 patients (41.7%)
during a mean follow-up of 14277378 days. The majority of
AF recurrences occurred during the ﬁrst 6 months of follow-
up (69.7%). Late recurrences (over 12 months) were, on the
other hand, relatively rare (15.1%, po0.001). Eight patients out
of those 33 remained asymptomatic and AF-free after re-
initiation of the previously ineffective antiarrhythmic drugs
(amiodarone in 3, propafenon in 4 and sotalol in 1 patient)
and 3 patients refused to undergo a repeat procedure and
continued to have AF recurrences. Thus, 22 of the 33 (66.6%)
patients were scheduled for a repeat procedure.
Repeat ablation procedures
All patients were in SR at the time of the second procedure.
The mean procedural and ﬂuoroscopy times of the second
procedure were 16076 min (125–220 min, median 160 min)
and 16.371.4 min (8–29 min, median 15 min), respectively.
No PV stenosis was found in any patient. In those 22 patients,
a total of 85 PVs were identiﬁed, with left common PVs in 3
patients. ER of at least one PV was found in all patients. In most
patients, multiple PVs exhibited ER: 4 PVs in 3 (13.6%) patients, 3
PVs in 9 (40.9%) patients, 2 PVs in 7 (31.8%), and a single PV in 3
(13.6%) patients. With regard to individual PVs, recovered PV
conduction was present in 15 (78.9%) of 19 left superior PVs, 13
(68.4%) of 19 left inferior PVs, 3 (100%) of 3 left common PVs, 13
(59.1%) of 22 right superior PVs, and 12 (54.5%) of 22 right inferior
PVs (p¼NS between individual PVs, po0.01 for left common PV
vs. any other PV). Majority of pulmonary veins presented with
only a single site of electrical reconduction (Fig. 2).
In two patients we were not able to determine the exact
location of gaps in every vein. In the ﬁrst patient we had to
reisolate the left common PV ablating around the wholecircumference; in another patient all four separate PVs
showed electrical activity almost equivalent to that seen
prior to any ablation. All four veins had to be reisolated with
wide antral circumferential lesions.
Location of PV reconduction
In the left superior PV, majority of gaps were located at both
the anterior superior (29.2%) and anterior inferior (62.5%)
quadrants of the vein (Fig. 3), i.e. on the lateral ridge between
the vein and the left atrial appendage, and on the carina
between the upper and lower veins. Posterior inferior quadrant
was the source of ER only in 8.3% whereas no gaps were found
in the posterior superior quadrant (po0.01). In the left inferior
PV, 56.3% and 31.2% of gaps were located at the anterior
superior and anterior inferior quadrants, respectively. Posterior
superior quadrant was the source of ER only in 12.5% whereas
no gaps were found in the posterior inferior quadrant (po0.01).
In the right superior PV, 75% of ERs were located at the
posterior superior quadrant of the vein, whereas 25% of the ERs
were situated in the anterior inferior (i.e. anterior septal)
quadrant and none at the remaining anterior superior and
posterior inferior quadrants (Fig. 3). Sites of ER in the right
inferior PV were scattered evenly around the whole circumfer-
ence of the vein and no typical location of ERs was identiﬁed:
21% of gaps were placed at anterior superior, anterior inferior
and posterior inferior quadrants, respectively, and 37% of gaps
were located at the posterior superior quadrant.
RF energy parameters at initial PVI
Retrospective analysis revealed that patients with and with-
out recurrent AF after initial PVI did not have signiﬁcantly
different numbers of RF applications or total RF delivery
times in all PVs (Table 2). When separating PVs into those
with and without isolation at the reablation procedure, the
number of RF applications and total RF delivery time were not
signiﬁcantly different as well (Table 3).
Fig. 3 – A and B – Schematic distribution of gaps around the pulmonary vein antra. The red dots represent the exact location of
gaps of electrical reconnection for all patients. The majority of gaps were located in both the superior and inferior anterior
quadrants of the left superior (LSPV) and left inferior pulmonary veins (LIPV) and/or the carina between those veins. In the
right superior pulmonary vein (RSPV), the reconnections were found either in the posterior superior quadrant of the vein or in
the septal inferior aspect. Electrical reconnections in the right inferior pulmonary vein (RIPV) were scattered around the whole
venous circumference. C – An example of patient #20. Short left common trunk of the left PVs was isolated at the roof and at
the anterior ridge at the level of the LIPV (2 gaps, red arrows). RSPV was isolated in the posterior superior quadrant (1 gap, red
arrow) and RIPV was isolated on the posterior wall and anterior inferior quadrant (2 gaps, red arrows). D – An example of the
isolation of the RSPV in the same patient. PV potentials (black arrow) disappear during RF application. (For interpretation of
the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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During a mean follow-up of 3907122 days after the second
procedure, freedom from AF off antiarrhythmic drugs was
achieved in 18 of 22 patients (90.9%). Two patients had to use
amiodarone to prevent recurrent AF episodes. Two patients
developed persistent AF despite medication with amiodar-
one; one of them underwent permanent pacemaker implan-
tation followed by AV node modiﬁcation. In total, stable SRwas restored in 74 of 79 patients (93.7%) after one or two
ablations. Of those 74 patients, 10 patients (13.5%) remained
using antiarrhythmic drugs.Discussion
The main ﬁndings of this study were as follows. (1) In
patients with paroxysmal AF undergoing PVI using PVAC
Table 2 – Comparison of number of RF applications and total RF energy delivery time needed to achieve PVI between AF-
free patients (AF-) and patients with AF recurrence (AFþ) during the initial procedure. LCPV – left common pulmonary vein,
LSPV – left superior pulmonary vein, LIPV – left inferior pulmonary vein, RSPV – right superior pulmonary vein, RIPV – right
inferior pulmonary vein.
LCPV LSPV LIPV RSPV RIPV
Number of RF applications AFþ 8.773.4 6.673.4 5.673.1 4.872.4 3.871.6
AF- 1474.0 6.573.8 5.873.5 4.572.0 4.673.1
p NS NS NS NS NS
Total RF energy delivery time AFþ 4677192 3177171 2567116 217776 190762
AF- 6717197 3277185 2807169 2377101 2447176
p N.A. NS NS NS NS
Table 3 – Comparison of the number of RF applications and total RF energy delivery time between isolated (PVIþ) and non-
isolated (PVI-) pulmonary veins during the reablation procedure. LCPV – left common pulmonary vein, LSPV – left superior
pulmonary vein, LIPV – left inferior pulmonary vein, RSPV – right superior pulmonary vein, RIPV – right inferior pulmonary
vein, N.A.¼not applicable (since all LCPVs were found non-isolated).
LCPV LSPV LIPV RSPV RIPV
Number of RF applications PVIþ N.A. 5.070.7 6.373.7 6.072.3 3.771.8
PVI- N.A. 7.373.8 5.372.8 3.972.0 3.871.5
p N.A. NS NS 0.08 NS
Total RF energy delivery time PVIþ N.A. 253752 241792 255786 198775
PVI- N.A. 3427194 2637124 191755 184751
p N.A. NS NS 0.09 NS
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Recurrent AF after PVI using PVAC was associated in all
patients with ER of the LA-PVs junction. Conduction gaps
after PVI using this multielectrode ablation technique
occurred at a high incidence at the anterior ridge between
the left PVs and appendage and at the carina between the left
PVS. In septal PVs, on the other hand, the prevalent location
of ER was the posterior superior quadrant of the right super-
ior PV, while no speciﬁc location of ER was identiﬁed in the
right inferior PV. (3) Most reconnected PVs presented with
only one site of ER and all gaps could be eliminated by RF
ablation using 3D electroanatomical mapping with acceptable
procedural and ﬂuoroscopic time.Tachycardia recurrence
All patients in our study presented with AF as the only
recurrent arrhythmia. Neither ATs nor typical AFLs were
present after PVI. The absence of the latter arrhythmia may
be explained by the fact that CTI ablation was performed in
patients, in whom typical AFL could be induced during the
initial procedure. Typical AFL represents the most common
recurrent arrhythmia during the early period after PVI if the
tachycardia was documented before and CTI ablation was not
performed together with the isolation of the PVs [7]. More-
over, CTI ablation procedure was previously proven to be
extremely safe by our and many other author groups [8,9].
Absence of ATs after PVI, however, is less clear. PV
tachycardia is a relatively common ﬁnding in patients with
recurrent atrial tachyarrhythmias after PVI using RF currentand point-by-point technique [10,11]. The possible explana-
tion could be that a majority of PVs in our study were
electrically reconnected with the LA through a singular gap.
One gap obviously cannot provide adequate arrhythmic
substrate for a localized reentry unlike multiple gaps. How-
ever, not all patients presented with only singular gap at the
second procedure and another explanation is that the patient
cohort was too small to detect the presence of this arrhyth-
mia. Fürnkranz et al [12] also showed a very small proportion
of recurrent atrial tachycardias (4%) in a population of 71
patients who underwent cryoballoon based PVI. The authors
speculate that the possible cause of such a low incidence of
atrial tachycardias in their study might be explained by
different histologic features of cryolesions, which are unlike
RF lesions clearly demarcated from normal myocardium and
constitute a difference with respect to the creation of a
reentrant circuit [13]. Low incidence of ATs in our study
might be in part also explained by the different formation
of the circumferential ablation lesion that is created by
phased RF application in both bipolar and unipolar modes,
making the lesion possibly more contiguous.Predilection sites of electrical reconnection
Published data about PV reconnection and completeness of
ablation lines in symptomatic patients who were previously
subjected to PVI and the creation of linear lesions using a
“point-by-point” approach under 3D guidance in the LA are
relatively rare, while such data in asymptomatic patients are
almost absent [11,14–16]. Novel ablation tools have not been
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to date. This is the ﬁrst study to show the distribution of PV
electrical reconnections after initial PVI using this novel
technology of phased-array RF ablation and a multipolar
circular ablation catheter.
The main ﬁnding of our study is that all patients who
come back for repeat PVI after an initial procedure using the
PVAC catheter had return of conduction in at least one of the
PVs, and in all but right inferior PV the sites of ER are located
in predictable areas. In the left PVs the typical sites of ER
found in our study after PVAC ablation perfectly matched the
sites of gaps found after conventional “point-by-point” RF
ablation (i.e. intervenous carina and left atrial appendage-left
venous ridge)[11,16] suggesting that the most probable reason
for reconnection may be uniformly thicker musculature of
the sleeves of myocardium located at the lateral ridge and
intervenous carina. The creation of RF lesion depends mainly
on energy settings, contact force and duration of RF delivery,
while other uncontrollable factors like the cooling effect of
the surrounding anatomical structures may also play a role.
Studies with novel ablation catheters enabling contact force
measurement showed that anterior quadrants (i.e. lateral
ridge) of the left veins as well as the carina between the
veins are sites with the lowest applied contact force during
“point-by-point” ablation [17]. Thus, not only muscle thick-
ness but also low contact force applied in these regions may
be responsible for high occurrence of ER. The only sensible
way how to increase efﬁcacy of the PVAC on the lateral ridge
and intervenous carina might be to decrease the bipolar to
unipolar ratio of the RF energy to 2:1 or even 1:1, which would
cause deeper lesions [18]. Deeper lesions, on the other hand,
always harbor the risk of uncontrolled damage to the sur-
rounding tissue. We might speculate that such an approach
would be still safe as there is no collateral damage likely in
anterior segments of the vein, while a 4:1 energy ratio on the
posterior wall is sufﬁciently effective. Unfortunately such an
approach would make PVAC less attractive tool (not single
shot).
Another aspect that has to be addressed is the lower
efﬁcacy of PVAC in bigger veins, which was also documented
in other studies [19]. Isolation of the big left common trunk of
the PVs is especially troublesome. Left common PVs required
more number of RF applications and longer RF energy
application when compared to any other PV. In three of nine
cases we were not able to accomplish its electrical isolation.
All those three patients presented with recurrent arrhythmia.
On the right side the typical places of ER were slightly
different from what we could have expected after point-by-
point ablation: instead of typical roof and intervenous ridge
location we found clustering of gaps in the posterior superior
and anterior (septal) inferior quadrants of the right superior
PV and no typical “reconnection pattern” in the right inferior
PV. Reasons for such differences between point-by-point and
PVAC ablation in the right PVs remain unclear, but we might
speculate that these regions somehow inherently suffer from
contact force problems during PVAC ablation. Based on the
results of our study and our experience, we suggest observing
carefully the delivered power into individual pairs of the
PVAC during RF ablation and to use rather 2:1 energy setting
in both right PVs. Careful monitoring of the position of theesophagus (for instance using ICE) remains mandatory.
Higher energy settings were shown to be safe and led to
shorter ﬂuoroscopy and procedure times in the human
setting [20]. Other studies may be needed to prove that such
an approach is both effective and safe.Clinical success
Arrhythmia-free survival off antiarrhythmic drugs in our
study reached 67% at 12 months after the initial procedure,
which is within the range of 61–83% reported in the literature
[4,5,20]. Most reconnected PVs presented with only one site of
ER and all gaps could be eliminated safely by RF ablation
using 3D electroanatomical mapping with acceptable proce-
dural and ﬂuoroscopic time. In total, 93.7% of patients in our
study remained in stable SR over the mean follow-up period
of 46 months at the cost of repeat procedure in 28% of them
and with approximately 14% of them still using antiarrhyth-
mic medication. Our mid-term follow-up data suggests that
redo PVI after circumferential ablation using a PVAC may be
justiﬁed assessing and treating the reconnected veins.Limitations
The major limitation of the study is the relatively low number
of patients undergoing redo procedures after failure of the
index procedure using PVAC catheter. Despite this we were
able to demonstrate a degree of uniformity of the location of
ERs around all but the right inferior PV.
Although extreme caution was paid to proper mapping of
the PV antra, we cannot completely exclude the possibility of
misdiagnosing the gap location. However we ﬁrmly believe
that any error would be no more than one adjacent segment
on the clock face scheme. In two patients, however, we were
not able to determine the exact location of reconnection,
since in both patients the electrical properties of the veins
resembled the previously untreated veins.Conclusions
PVI using a multielectrode ablation catheter is an effective
and safe modality for treatment of patients with paroxysmal
AF with clinical efﬁcacy reaching 67% after a single procedure
at 12 months and over 90% after a repeated procedure. PVAC
technology substantially reduces both procedure and ﬂuoro-
scopic times. Typical sites of ER are the carina between the
left veins, lateral ridge of the left veins and posterior superior
quadrant of the right superior PV. On the contrary, the right
inferior PV seems to have no typical “reconnection proﬁle”
and sites of ERs may be found scattered around the whole
venous circumference.
Knowledge of the typical sites of ER is key information to
achieve better long-term success rates for the procedure.
We hypothesize that increasing the unipolar to bipolar ratio
of RF current delivery during PV isolation using PVAC in regions
that are prone to reconnection might lead to a higher overall
success rate. Such an approach has to be tested prospectively in
further studies with respect to safety and efﬁcacy.
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